Atossa Therapeutics Inc (ATOS) Ownership

$4.42

$0.08 (1.84%)
Last update: 05:07 AM EST
Day's range
$4.2
Day's range
$4.54

Atossa Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 6.15 M $3.63 B   1.14% 4.76%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 2.06 M $1.22 M   33.20% 1.60%
BLACKROCK, INC. 02/12/2026 2.00 M $1.18 M   0.00% 1.55%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.37 M $809.62 M   0.71% 1.06%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.24 M $733.29 K   -25.52% 0.96%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 1.05 M $618.49 K   100.00% 0.81%
CITADEL ADVISORS LLC 02/17/2026 648.12 K $382.39 M   146.09% 0.50%
STATE STREET CORP 02/13/2026 596.49 K $351.93 K   31.24% 0.46%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 582.59 K $343.73 K   165.29% 0.45%
UBS GROUP AG 01/29/2026 390.01 K $230.11 K   49.59% 0.30%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 266.01 K $156.95 K   7.00% 0.21%
JANE STREET GROUP, LLC 02/12/2026 246.00 K $145.14 M   51.45% 0.19%
XTX TOPCO LTD 02/17/2026 169.26 K $99.86 K   581.16% 0.13%
CITADEL ADVISORS LLC 02/17/2026 85.80 K $50.62 M   240.48% 0.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 80.00 K $47.20 K   0.00% 0.06%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 79.41 K $46.00 K   -18.37% 0.06%
BANK OF AMERICA CORP /DE/ 02/17/2026 67.65 K $39.92 M   -56.40% 0.05%
MORGAN STANLEY 02/13/2026 61.50 K $36.29 K   -45.26% 0.05%
JANE STREET GROUP, LLC 02/12/2026 40.50 K $23.90 M   100.00% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 38.50 K $22.72 K   3.77% 0.03%
JPMORGAN CHASE & CO 02/11/2026 38.07 K $22.46 K   -0.39% 0.03%
CITADEL ADVISORS LLC 02/17/2026 31.80 K $18.76 M   -5.64% 0.02%
REGIONS FINANCIAL CORP 01/27/2026 30.00 K $17.70 K   0.00% 0.02%
LPL FINANCIAL LLC 02/11/2026 29.47 K $17.39 K   3.20% 0.02%
R SQUARED LTD 01/30/2026 28.10 K $16.58 K   100.00% 0.02%
TWO SIGMA SECURITIES, LLC 02/17/2026 24.51 K $14.46 K   100.00% 0.02%
SIGMA PLANNING CORP 01/30/2026 24.00 K $14.16 K   0.00% 0.02%
TWO SIGMA INVESTMENTS, LP 02/17/2026 23.45 K $13.84 K   100.00% 0.02%
PFG INVESTMENTS, LLC 01/26/2026 21.75 K $12.83 K   2.35% 0.02%
BAADER BANK AKTIENGESELLSCHAFT 02/05/2026 21.36 K $7.77 K   100.00% 0.02%
LVM CAPITAL MANAGEMENT LTD/MI 01/12/2026 21.00 K $12.00 K   0.00% 0.02%
STONEX GROUP INC. 02/12/2026 19.87 K $11.72 K   100.00% 0.02%
TWO SIGMA ADVISERS, LP 02/17/2026 18.30 K $10.80 K   100.00% 0.01%
GREENBERG FINANCIAL GROUP 01/22/2026 18.22 K $10.75 M   100.00% 0.01%
DNB ASSET MANAGEMENT AS 02/05/2026 15.60 K $9.20 K   0.00% 0.01%
RAYMOND JAMES FINANCIAL INC 02/18/2026 11.32 K $6.68 K   4.70% 0.01%
BANK OF NEW YORK MELLON CORP 02/10/2026 11.15 K $6.58 K   0.00% 0.01%
J. L. BAINBRIDGE & CO., INC. 01/14/2026 11.12 K $6.56 K   0.00% 0.01%
FOCUS FINANCIAL NETWORK, INC. 01/12/2026 10.35 K $6.11 K   1.97% 0.01%
JANNEY MONTGOMERY SCOTT LLC 02/11/2026 10.00 K $6.00 K   0.00% 0.01%
ADVISOR GROUP HOLDINGS, INC. 02/17/2026 8.85 K $5.22 K   0.00% 0.01%
GROUP ONE TRADING, L.P. 02/12/2026 6.66 K $3.93 K   100.00% 0.01%
NEWEDGE ADVISORS, LLC 02/18/2026 5.00 K $2.95 K   0.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 4.00 K $2.36 M   58.94% 0.00%
HUNTINGTON NATIONAL BANK 02/09/2026 3.00 K $1.77 K   0.00% 0.00%
HARBOUR INVESTMENTS, INC. 02/09/2026 1.66 K $977   -3.21% 0.00%
SBI SECURITIES CO., LTD. 02/03/2026 1.57 K $923   -0.06% 0.00%
TD WATERHOUSE CANADA INC. 01/27/2026 1.56 K $910   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 1.50 K $883   0.47% 0.00%
ROYAL BANK OF CANADA 02/17/2026 943 $1.00 K   26.58% 0.00%

Atossa Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 85 institutional investors and hedge funds held shares of Atossa Therapeutics Inc. The most heavily invested institutionals were:

VANGUARD GROUP INC: 6.15 M

RENAISSANCE TECHNOLOGIES LLC: 2.06 M

BlackRock, Inc.: 2 M

GEODE CAPITAL MANAGEMENT, LLC: 1.37 M

MILLENNIUM MANAGEMENT LLC: 1.24 M

JACOBS LEVY EQUITY MANAGEMENT, INC: 1.05 M

16.99% of Atossa Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 27.02 M shares in the last 24 months. This purchase volume represents approximately $119.44 M in transactions.